| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein antigen binding | 5.35e-07 | 16 | 85 | 4 | GO:1990405 | |
| GeneOntologyMolecularFunction | complement binding | 1.00e-05 | 32 | 85 | 4 | GO:0001848 | |
| GeneOntologyMolecularFunction | complement component C3b binding | 1.59e-05 | 12 | 85 | 3 | GO:0001851 | |
| GeneOntologyMolecularFunction | complement component C3b receptor activity | 1.79e-05 | 2 | 85 | 2 | GO:0004877 | |
| GeneOntologyMolecularFunction | complement component C4b receptor activity | 1.79e-05 | 2 | 85 | 2 | GO:0001861 | |
| GeneOntologyMolecularFunction | complement receptor activity | 2.62e-05 | 14 | 85 | 3 | GO:0004875 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | FLNA FLNB ITGA11 CCT8 KDR SIRPB1 SIRPA ITGA4 ITGB2 CNGA3 SIRPG | 4.61e-05 | 599 | 85 | 11 | GO:0050839 |
| GeneOntologyMolecularFunction | complement component C4b binding | 5.36e-05 | 3 | 85 | 2 | GO:0001855 | |
| GeneOntologyMolecularFunction | protein binding involved in heterotypic cell-cell adhesion | 5.80e-05 | 18 | 85 | 3 | GO:0086080 | |
| GeneOntologyMolecularFunction | immunoglobulin receptor binding | 9.37e-05 | 21 | 85 | 3 | GO:0034987 | |
| GeneOntologyMolecularFunction | opsonin binding | 1.60e-04 | 25 | 85 | 3 | GO:0001846 | |
| GeneOntologyMolecularFunction | cell adhesion mediator activity | 3.11e-04 | 76 | 85 | 4 | GO:0098631 | |
| GeneOntologyMolecularFunction | opsonin receptor activity | 4.93e-04 | 8 | 85 | 2 | GO:0001847 | |
| GeneOntologyMolecularFunction | antigen binding | 1.31e-03 | 190 | 85 | 5 | GO:0003823 | |
| GeneOntologyMolecularFunction | phosphoprotein binding | 1.57e-03 | 117 | 85 | 4 | GO:0051219 | |
| GeneOntologyMolecularFunction | 5S rRNA binding | 1.58e-03 | 14 | 85 | 2 | GO:0008097 | |
| GeneOntologyMolecularFunction | ribonucleoprotein complex binding | 1.87e-03 | 206 | 85 | 5 | GO:0043021 | |
| GeneOntologyMolecularFunction | snRNP binding | 2.07e-03 | 16 | 85 | 2 | GO:0070990 | |
| GeneOntologyMolecularFunction | cell-cell adhesion mediator activity | 2.24e-03 | 61 | 85 | 3 | GO:0098632 | |
| GeneOntologyMolecularFunction | mRNA regulatory element binding translation repressor activity | 2.34e-03 | 17 | 85 | 2 | GO:0000900 | |
| GeneOntologyMolecularFunction | actin filament binding | 2.85e-03 | 227 | 85 | 5 | GO:0051015 | |
| GeneOntologyMolecularFunction | protein phosphorylated amino acid binding | 3.19e-03 | 69 | 85 | 3 | GO:0045309 | |
| GeneOntologyBiologicalProcess | negative regulation of I-kappaB phosphorylation | 2.69e-07 | 4 | 85 | 3 | GO:1903720 | |
| GeneOntologyBiologicalProcess | negative regulation of macrophage inflammatory protein 1 alpha production | 6.71e-07 | 5 | 85 | 3 | GO:0071641 | |
| GeneOntologyBiologicalProcess | negative regulation of humoral immune response | 9.93e-07 | 19 | 85 | 4 | GO:0002921 | |
| GeneOntologyBiologicalProcess | regulation of macrophage inflammatory protein 1 alpha production | 3.73e-06 | 8 | 85 | 3 | GO:0071640 | |
| GeneOntologyBiologicalProcess | negative regulation of complement activation, classical pathway | 3.73e-06 | 8 | 85 | 3 | GO:0045959 | |
| GeneOntologyBiologicalProcess | positive regulation of cell adhesion | FLNA FBLN2 EFNB2 DOCK8 KDR SIRPB1 ACTL6A SIRPA ITGA4 CR1 ITGB2 SIRPG | 4.35e-06 | 579 | 85 | 12 | GO:0045785 |
| GeneOntologyBiologicalProcess | regulation of complement activation | 4.38e-06 | 27 | 85 | 4 | GO:0030449 | |
| GeneOntologyBiologicalProcess | regulation of humoral immune response | 4.82e-06 | 60 | 85 | 5 | GO:0002920 | |
| GeneOntologyBiologicalProcess | negative regulation of chemokine (C-C motif) ligand 5 production | 5.57e-06 | 9 | 85 | 3 | GO:0071650 | |
| GeneOntologyBiologicalProcess | macrophage inflammatory protein-1 alpha production | 5.57e-06 | 9 | 85 | 3 | GO:0071608 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte cell-cell adhesion | 6.31e-06 | 317 | 85 | 9 | GO:1903039 | |
| GeneOntologyBiologicalProcess | regulation of I-kappaB phosphorylation | 7.94e-06 | 10 | 85 | 3 | GO:1903719 | |
| GeneOntologyBiologicalProcess | regulation of complement activation, classical pathway | 7.94e-06 | 10 | 85 | 3 | GO:0030450 | |
| GeneOntologyBiologicalProcess | negative regulation of humoral immune response mediated by circulating immunoglobulin | 1.45e-05 | 12 | 85 | 3 | GO:0002924 | |
| GeneOntologyBiologicalProcess | cellular response to interleukin-12 | 1.87e-05 | 13 | 85 | 3 | GO:0071349 | |
| GeneOntologyBiologicalProcess | monocyte extravasation | 1.87e-05 | 13 | 85 | 3 | GO:0035696 | |
| GeneOntologyBiologicalProcess | negative regulation of complement activation | 2.38e-05 | 14 | 85 | 3 | GO:0045916 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | FLNA FBLN2 EFNB2 DOCK8 KDR SIRPB1 ACTL6A SIRPA ITGA4 CR1 MDGA1 ITGB2 SPINK5 SIRPG | 2.41e-05 | 927 | 85 | 14 | GO:0030155 |
| GeneOntologyBiologicalProcess | cellular extravasation | 2.67e-05 | 85 | 85 | 5 | GO:0045123 | |
| GeneOntologyBiologicalProcess | regulation of chemokine (C-C motif) ligand 5 production | 2.97e-05 | 15 | 85 | 3 | GO:0071649 | |
| GeneOntologyBiologicalProcess | positive regulation of cell-cell adhesion | 3.20e-05 | 389 | 85 | 9 | GO:0022409 | |
| GeneOntologyBiologicalProcess | complement activation, classical pathway | 3.22e-05 | 44 | 85 | 4 | GO:0006958 | |
| GeneOntologyBiologicalProcess | chemokine (C-C motif) ligand 5 production | 3.64e-05 | 16 | 85 | 3 | GO:0071609 | |
| GeneOntologyBiologicalProcess | negative regulation of B cell mediated immunity | 3.64e-05 | 16 | 85 | 3 | GO:0002713 | |
| GeneOntologyBiologicalProcess | negative regulation of immunoglobulin mediated immune response | 3.64e-05 | 16 | 85 | 3 | GO:0002890 | |
| GeneOntologyBiologicalProcess | response to interleukin-12 | 3.64e-05 | 16 | 85 | 3 | GO:0070671 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 4.82e-05 | 410 | 85 | 9 | GO:0031589 | |
| GeneOntologyBiologicalProcess | positive regulation of activation of membrane attack complex | 5.02e-05 | 3 | 85 | 2 | GO:0001970 | |
| GeneOntologyBiologicalProcess | negative regulation of interferon-beta production | 7.32e-05 | 20 | 85 | 3 | GO:0032688 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte cell-cell adhesion | 9.33e-05 | 447 | 85 | 9 | GO:1903037 | |
| GeneOntologyBiologicalProcess | I-kappaB phosphorylation | 9.83e-05 | 22 | 85 | 3 | GO:0007252 | |
| GeneOntologyBiologicalProcess | regulation of humoral immune response mediated by circulating immunoglobulin | 9.83e-05 | 22 | 85 | 3 | GO:0002923 | |
| GeneOntologyBiologicalProcess | regulation of activation of membrane attack complex | 1.00e-04 | 4 | 85 | 2 | GO:0001969 | |
| GeneOntologyBiologicalProcess | cellular response to type II interferon | 1.09e-04 | 114 | 85 | 5 | GO:0071346 | |
| GeneOntologyBiologicalProcess | humoral immune response mediated by circulating immunoglobulin | 1.25e-04 | 62 | 85 | 4 | GO:0002455 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 1.26e-04 | 270 | 85 | 7 | GO:0007160 | |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion | 1.35e-04 | 580 | 85 | 10 | GO:0022407 | |
| GeneOntologyBiologicalProcess | negative regulation of nitric oxide biosynthetic process | 1.45e-04 | 25 | 85 | 3 | GO:0045019 | |
| GeneOntologyBiologicalProcess | negative regulation of nitric oxide metabolic process | 1.45e-04 | 25 | 85 | 3 | GO:1904406 | |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 1.62e-04 | 124 | 85 | 5 | GO:0007229 | |
| GeneOntologyBiologicalProcess | leukocyte cell-cell adhesion | 1.75e-04 | 486 | 85 | 9 | GO:0007159 | |
| GeneOntologyBiologicalProcess | phagocytosis, engulfment | 1.89e-04 | 69 | 85 | 4 | GO:0006911 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell activation | 1.96e-04 | 290 | 85 | 7 | GO:0050870 | |
| GeneOntologyBiologicalProcess | complement activation | 2.00e-04 | 70 | 85 | 4 | GO:0006956 | |
| GeneOntologyBiologicalProcess | activation of membrane attack complex | 2.49e-04 | 6 | 85 | 2 | GO:0001905 | |
| GeneOntologyBiologicalProcess | response to type II interferon | 2.94e-04 | 141 | 85 | 5 | GO:0034341 | |
| GeneOntologyBiologicalProcess | plasma membrane invagination | 3.04e-04 | 78 | 85 | 4 | GO:0099024 | |
| GeneOntologyBiologicalProcess | negative regulation of phagocytosis | 3.37e-04 | 33 | 85 | 3 | GO:0050765 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | FLNA ITGA11 EFNB2 DOCK8 SIRPB1 ACTL6A SIRPA ITGA4 CR1 MDGA1 ITGB2 ADGRL3 SIRPG | 4.45e-04 | 1077 | 85 | 13 | GO:0098609 |
| GeneOntologyBiologicalProcess | membrane invagination | 4.61e-04 | 87 | 85 | 4 | GO:0010324 | |
| GeneOntologyBiologicalProcess | negative regulation of serine-type peptidase activity | 4.62e-04 | 8 | 85 | 2 | GO:1902572 | |
| GeneOntologyBiologicalProcess | negative regulation of serine-type endopeptidase activity | 4.62e-04 | 8 | 85 | 2 | GO:1900004 | |
| GeneOntologyBiologicalProcess | negative regulation of chemokine production | 5.13e-04 | 38 | 85 | 3 | GO:0032682 | |
| GeneOntologyBiologicalProcess | positive regulation of cell activation | 5.27e-04 | 449 | 85 | 8 | GO:0050867 | |
| GeneOntologyBiologicalProcess | positive regulation of complement activation | 5.93e-04 | 9 | 85 | 2 | GO:0045917 | |
| GeneOntologyBiologicalProcess | regulation of T cell activation | 6.00e-04 | 458 | 85 | 8 | GO:0050863 | |
| GeneOntologyBiologicalProcess | ameboidal-type cell migration | 6.14e-04 | 577 | 85 | 9 | GO:0001667 | |
| GeneOntologyBiologicalProcess | phagocytosis, recognition | 6.90e-04 | 42 | 85 | 3 | GO:0006910 | |
| GeneOntologyBiologicalProcess | regulation of nitric oxide biosynthetic process | 6.95e-04 | 97 | 85 | 4 | GO:0045428 | |
| GeneOntologyBiologicalProcess | regulation of serine-type peptidase activity | 7.39e-04 | 10 | 85 | 2 | GO:1902571 | |
| GeneOntologyBiologicalProcess | regulation of serine-type endopeptidase activity | 7.39e-04 | 10 | 85 | 2 | GO:1900003 | |
| GeneOntologyBiologicalProcess | negative regulation of cytoplasmic translation | 7.39e-04 | 10 | 85 | 2 | GO:2000766 | |
| GeneOntologyBiologicalProcess | negative regulation of JNK cascade | 7.40e-04 | 43 | 85 | 3 | GO:0046329 | |
| GeneOntologyBiologicalProcess | negative regulation of cytokine production involved in inflammatory response | 7.40e-04 | 43 | 85 | 3 | GO:1900016 | |
| GeneOntologyBiologicalProcess | regulation of nitric oxide metabolic process | 7.80e-04 | 100 | 85 | 4 | GO:0080164 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte activation | 1.06e-03 | 385 | 85 | 7 | GO:0051251 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | FLNA FLNB ABLIM1 EFNB2 COBL KDR PRMT3 CUL7 ITGA4 BRSK1 ITGB2 DCLK1 BRWD3 | 1.16e-03 | 1194 | 85 | 13 | GO:0000902 |
| GeneOntologyBiologicalProcess | nitric oxide biosynthetic process | 1.19e-03 | 112 | 85 | 4 | GO:0006809 | |
| GeneOntologyBiologicalProcess | endocardium development | 1.27e-03 | 13 | 85 | 2 | GO:0003157 | |
| GeneOntologyBiologicalProcess | regulation of complement-dependent cytotoxicity | 1.27e-03 | 13 | 85 | 2 | GO:1903659 | |
| GeneOntologyBiologicalProcess | hematopoietic progenitor cell differentiation | 1.34e-03 | 197 | 85 | 5 | GO:0002244 | |
| GeneOntologyBiologicalProcess | cell recognition | 1.37e-03 | 198 | 85 | 5 | GO:0008037 | |
| GeneOntologyBiologicalProcess | negative regulation of type I interferon production | 1.44e-03 | 54 | 85 | 3 | GO:0032480 | |
| GeneOntologyBiologicalProcess | nitric oxide metabolic process | 1.58e-03 | 121 | 85 | 4 | GO:0046209 | |
| GeneOntologyBiologicalProcess | negative regulation of protein metabolic process | CPEB2 FLNA SLC8A1 CPEB4 MLLT1 PRMT3 SIRPB1 SIRPA CR1 RPL5 SPINK5 SIRPG | 1.63e-03 | 1088 | 85 | 12 | GO:0051248 |
| GeneOntologyBiologicalProcess | positive regulation of immune system process | EFNB2 DOCK8 PARP9 SIRPB1 ACTL6A SIRPA C6 ITGA4 CR1 CR1L CR2 ITGB2 SIRPG | 1.65e-03 | 1242 | 85 | 13 | GO:0002684 |
| GeneOntologyBiologicalProcess | reactive nitrogen species metabolic process | 1.68e-03 | 123 | 85 | 4 | GO:2001057 | |
| GeneOntologyCellularComponent | focal adhesion | 6.39e-05 | 431 | 85 | 9 | GO:0005925 | |
| GeneOntologyCellularComponent | cell-substrate junction | 7.88e-05 | 443 | 85 | 9 | GO:0030055 | |
| GeneOntologyCellularComponent | transcription elongation factor complex | 7.96e-05 | 56 | 85 | 4 | GO:0008023 | |
| GeneOntologyCellularComponent | cell surface | FCRL2 ITGA11 IGF2R KDR SIRPB1 SIRPA ITGA4 LY75 CR1 CR1L MDGA1 CR2 ITGB2 SIRPG | 1.46e-04 | 1111 | 85 | 14 | GO:0009986 |
| GeneOntologyCellularComponent | anchoring junction | FLNA FLNB KLHL24 ITGA11 SLC8A1 IGF2R EFNB2 RPS11 KDR ITGA4 ITGB2 RPL5 ADGRL3 | 1.51e-04 | 976 | 85 | 13 | GO:0070161 |
| GeneOntologyCellularComponent | external side of plasma membrane | 2.58e-04 | 519 | 85 | 9 | GO:0009897 | |
| GeneOntologyCellularComponent | integrin complex | 2.96e-04 | 32 | 85 | 3 | GO:0008305 | |
| GeneOntologyCellularComponent | axon | FLNA KLHL24 SLC8A1 CPEB4 COBL ITGA4 BRSK1 MDGA1 CNGA3 DCLK1 ADGRL3 | 9.49e-04 | 891 | 85 | 11 | GO:0030424 |
| GeneOntologyCellularComponent | actin filament bundle | 1.37e-03 | 118 | 85 | 4 | GO:0032432 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 1.79e-03 | 59 | 85 | 3 | GO:0098636 | |
| GeneOntologyCellularComponent | ficolin-1-rich granule membrane | 1.97e-03 | 61 | 85 | 3 | GO:0101003 | |
| GeneOntologyCellularComponent | distal axon | 1.97e-03 | 435 | 85 | 7 | GO:0150034 | |
| HumanPheno | Accessory carpal bones | 3.13e-05 | 2 | 29 | 2 | HP:0004232 | |
| HumanPheno | Bipartite calcaneus | 3.13e-05 | 2 | 29 | 2 | HP:0008127 | |
| Domain | Sushi | 3.81e-06 | 52 | 85 | 5 | PF00084 | |
| Domain | CCP | 4.60e-06 | 54 | 85 | 5 | SM00032 | |
| Domain | SUSHI | 5.52e-06 | 56 | 85 | 5 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 6.03e-06 | 57 | 85 | 5 | IPR000436 | |
| Domain | CEBP_ZZ | 1.22e-04 | 4 | 85 | 2 | IPR032296 | |
| Domain | AbLIM_anchor | 1.22e-04 | 4 | 85 | 2 | PF16182 | |
| Domain | YEATS | 1.22e-04 | 4 | 85 | 2 | IPR005033 | |
| Domain | YEATS | 1.22e-04 | 4 | 85 | 2 | PS51037 | |
| Domain | AbLIM_anchor | 1.22e-04 | 4 | 85 | 2 | IPR032402 | |
| Domain | CEBP_ZZ | 1.22e-04 | 4 | 85 | 2 | PF16366 | |
| Domain | RRM_7 | 1.22e-04 | 4 | 85 | 2 | PF16367 | |
| Domain | YEATS | 1.22e-04 | 4 | 85 | 2 | PF03366 | |
| Domain | Integrin_dom | 1.95e-04 | 25 | 85 | 3 | IPR032695 | |
| Domain | Ig_V-set | 2.95e-04 | 199 | 85 | 6 | IPR013106 | |
| Domain | IGv | 3.80e-04 | 75 | 85 | 4 | SM00406 | |
| Domain | VWFA | 5.33e-04 | 82 | 85 | 4 | PS50234 | |
| Domain | Calx_beta | 5.63e-04 | 8 | 85 | 2 | SM00237 | |
| Domain | HP | 5.63e-04 | 8 | 85 | 2 | PS51089 | |
| Domain | - | 5.63e-04 | 8 | 85 | 2 | 1.10.950.10 | |
| Domain | VHP | 5.63e-04 | 8 | 85 | 2 | PF02209 | |
| Domain | Villin_headpiece | 5.63e-04 | 8 | 85 | 2 | IPR003128 | |
| Domain | VHP | 5.63e-04 | 8 | 85 | 2 | SM00153 | |
| Domain | VWA | 5.84e-04 | 84 | 85 | 4 | SM00327 | |
| Domain | Calx_beta | 7.22e-04 | 9 | 85 | 2 | IPR003644 | |
| Domain | Calx-beta | 7.22e-04 | 9 | 85 | 2 | PF03160 | |
| Domain | - | 8.44e-04 | 663 | 85 | 10 | 2.60.40.10 | |
| Domain | IG_FLMN | 9.00e-04 | 10 | 85 | 2 | SM00557 | |
| Domain | VWF_A | 1.08e-03 | 99 | 85 | 4 | IPR002035 | |
| Domain | Filamin | 1.10e-03 | 11 | 85 | 2 | PF00630 | |
| Domain | FILAMIN_REPEAT | 1.10e-03 | 11 | 85 | 2 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 1.10e-03 | 11 | 85 | 2 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 1.10e-03 | 11 | 85 | 2 | IPR017868 | |
| Domain | Ig-like_fold | 1.36e-03 | 706 | 85 | 10 | IPR013783 | |
| Domain | V-set | 1.53e-03 | 184 | 85 | 5 | PF07686 | |
| Domain | FN_type2_col-bd | 1.80e-03 | 14 | 85 | 2 | IPR000562 | |
| Domain | FN2_2 | 1.80e-03 | 14 | 85 | 2 | PS51092 | |
| Domain | fn2 | 1.80e-03 | 14 | 85 | 2 | PF00040 | |
| Domain | FN2_1 | 1.80e-03 | 14 | 85 | 2 | PS00023 | |
| Domain | FN2 | 1.80e-03 | 14 | 85 | 2 | SM00059 | |
| Domain | C1-set | 1.91e-03 | 54 | 85 | 3 | PF07654 | |
| Domain | IGc1 | 2.12e-03 | 56 | 85 | 3 | SM00407 | |
| Domain | Ig_C1-set | 2.34e-03 | 58 | 85 | 3 | IPR003597 | |
| Domain | Integrin_alpha-2 | 2.99e-03 | 18 | 85 | 2 | IPR013649 | |
| Domain | Integrin_alpha2 | 2.99e-03 | 18 | 85 | 2 | PF08441 | |
| Domain | Integrin_alpha | 2.99e-03 | 18 | 85 | 2 | IPR000413 | |
| Domain | INTEGRIN_ALPHA | 2.99e-03 | 18 | 85 | 2 | PS00242 | |
| Domain | IG | 3.07e-03 | 421 | 85 | 7 | SM00409 | |
| Domain | Ig_sub | 3.07e-03 | 421 | 85 | 7 | IPR003599 | |
| Domain | Int_alpha_beta-p | 3.33e-03 | 19 | 85 | 2 | IPR013519 | |
| Domain | Int_alpha | 3.33e-03 | 19 | 85 | 2 | SM00191 | |
| Domain | FG_GAP | 4.46e-03 | 22 | 85 | 2 | PS51470 | |
| Domain | - | 4.67e-03 | 74 | 85 | 3 | 3.40.50.410 | |
| Domain | Actinin_actin-bd_CS | 4.87e-03 | 23 | 85 | 2 | IPR001589 | |
| Domain | ACTININ_2 | 4.87e-03 | 23 | 85 | 2 | PS00020 | |
| Domain | ACTININ_1 | 4.87e-03 | 23 | 85 | 2 | PS00019 | |
| Domain | FG-GAP | 5.29e-03 | 24 | 85 | 2 | PF01839 | |
| Domain | FG-GAP | 5.29e-03 | 24 | 85 | 2 | IPR013517 | |
| Domain | EGF_1 | 6.17e-03 | 255 | 85 | 5 | PS00022 | |
| Domain | IG_LIKE | 7.04e-03 | 491 | 85 | 7 | PS50835 | |
| Domain | EGF_2 | 7.23e-03 | 265 | 85 | 5 | PS01186 | |
| Domain | Ig-like_dom | 7.99e-03 | 503 | 85 | 7 | IPR007110 | |
| Pathway | BIOCARTA_BLYMPHOCYTE_PATHWAY | 3.60e-05 | 14 | 67 | 3 | M1473 | |
| Pathway | REACTOME_SIGNAL_REGULATORY_PROTEIN_FAMILY_INTERACTIONS | 3.60e-05 | 14 | 67 | 3 | MM15011 | |
| Pathway | REACTOME_SIGNAL_REGULATORY_PROTEIN_FAMILY_INTERACTIONS | 5.50e-05 | 16 | 67 | 3 | M925 | |
| Pathway | WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE | 6.65e-05 | 17 | 67 | 3 | M39733 | |
| Pathway | BIOCARTA_LAIR_PATHWAY | 6.65e-05 | 17 | 67 | 3 | M3952 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 1.02e-04 | 158 | 67 | 6 | MM14812 | |
| Pathway | PID_INTEGRIN_CS_PATHWAY | 2.47e-04 | 26 | 67 | 3 | M47 | |
| Pathway | REACTOME_HEMOSTASIS | FLNA SLC8A1 DOCK8 JCHAIN CAPZA2 SIRPB1 SIRPA ITGA4 ITGB2 SIRPG | 3.40e-04 | 571 | 67 | 10 | MM14472 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 5.38e-04 | 300 | 67 | 7 | M610 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 7.07e-04 | 85 | 67 | 4 | M16441 | |
| Pathway | BIOCARTA_LYMPHOCYTE_PATHWAY | 7.84e-04 | 9 | 67 | 2 | MM1534 | |
| Pathway | BIOCARTA_LYMPHOCYTE_PATHWAY | 7.84e-04 | 9 | 67 | 2 | M22008 | |
| Pathway | WP_IL1_SIGNALING_PATHWAY | 8.30e-04 | 39 | 67 | 3 | MM15996 | |
| Pathway | BIOCARTA_BLYMPHOCYTE_PATHWAY | 9.77e-04 | 10 | 67 | 2 | MM1354 | |
| Pathway | WP_COMPLEMENT_SYSTEM | 1.11e-03 | 96 | 67 | 4 | M39581 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 1.11e-03 | 96 | 67 | 4 | MM14592 | |
| Pathway | BIOCARTA_MONOCYTE_PATHWAY | 1.19e-03 | 11 | 67 | 2 | MM1436 | |
| Pathway | WP_NPHP1_DELETION_SYNDROME | 1.19e-03 | 11 | 67 | 2 | M48099 | |
| Pathway | BIOCARTA_MONOCYTE_PATHWAY | 1.19e-03 | 11 | 67 | 2 | M4956 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.39e-03 | 258 | 67 | 6 | MM14572 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 1.40e-03 | 102 | 67 | 4 | M39577 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 1.40e-03 | 102 | 67 | 4 | MM15830 | |
| Pathway | WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY | 1.61e-03 | 106 | 67 | 4 | M42535 | |
| Pubmed | 3.48e-11 | 4 | 86 | 4 | 30910815 | ||
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 36202053 | ||
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 15034021 | ||
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 26222253 | ||
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 12167615 | ||
| Pubmed | Signal regulatory protein alpha initiates cachexia through muscle to adipose tissue crosstalk. | 1.46e-08 | 3 | 86 | 3 | 31507080 | |
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 22988019 | ||
| Pubmed | Hypothermia-induced tyrosine phosphorylation of SIRPα in the brain. | 1.46e-08 | 3 | 86 | 3 | 22468987 | |
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 34917090 | ||
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 30894504 | ||
| Pubmed | Inhibitory regulation of osteoclast bone resorption by signal regulatory protein alpha. | 1.46e-08 | 3 | 86 | 3 | 19667119 | |
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 28669759 | ||
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 23022485 | ||
| Pubmed | Anti-SIRPα antibody immunotherapy enhances neutrophil and macrophage antitumor activity. | 1.46e-08 | 3 | 86 | 3 | 29158380 | |
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 25817792 | ||
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 12134038 | ||
| Pubmed | Central nervous system antigen P84 can serve as a substrate for neurite outgrowth. | 1.46e-08 | 3 | 86 | 3 | 2303162 | |
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 16141346 | ||
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 31883525 | ||
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 23504854 | ||
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 23842779 | ||
| Pubmed | Essential roles of SIRPα in homeostatic regulation of skin dendritic cells. | 1.46e-08 | 3 | 86 | 3 | 20955735 | |
| Pubmed | A role for SHPS-1/SIRPalpha in Concanavalin A-dependent production of MMP-9. | 1.46e-08 | 3 | 86 | 3 | 17825046 | |
| Pubmed | SIRPα deficiency accelerates the pathologic process in models of Parkinson disease. | 1.46e-08 | 3 | 86 | 3 | 31322787 | |
| Pubmed | Soluble SIRP-Alpha Promotes Murine Acute Lung Injury Through Suppressing Macrophage Phagocytosis. | 1.46e-08 | 3 | 86 | 3 | 35634325 | |
| Pubmed | The Rho kinase pathway regulates the migration of dendritic cells through SIRP-α. | 1.46e-08 | 3 | 86 | 3 | 22391241 | |
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 9348339 | ||
| Pubmed | Targeting SIRP-α protects from type 2-driven allergic airway inflammation. | 1.46e-08 | 3 | 86 | 3 | 21108471 | |
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 16920950 | ||
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 17109464 | ||
| Pubmed | Signal regulatory protein α negatively regulates mast-cell activation following FcεRI aggregation. | 1.46e-08 | 3 | 86 | 3 | 23504624 | |
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 2528587 | ||
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 23472187 | ||
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 25236797 | ||
| Pubmed | Deficiency in SIRP-α cytoplasmic recruitment confers protection from acute kidney injury. | 1.46e-08 | 3 | 86 | 3 | 31370677 | |
| Pubmed | A functional subset of CD8+ T cells during chronic exhaustion is defined by SIRPα expression. | 1.46e-08 | 3 | 86 | 3 | 30770827 | |
| Pubmed | Signal regulatory protein α protects podocytes through promoting autophagic activity. | 1.46e-08 | 3 | 86 | 3 | 30888336 | |
| Pubmed | Podocyte SIRPα reduction aggravates lupus nephritis via promoting T cell inflammatory responses. | 1.46e-08 | 3 | 86 | 3 | 38758648 | |
| Pubmed | Loss of microglial SIRPα promotes synaptic pruning in preclinical models of neurodegeneration. | 1.46e-08 | 3 | 86 | 3 | 33795678 | |
| Pubmed | Requirement of SIRPα for protective immunity against Leishmania major. | 1.46e-08 | 3 | 86 | 3 | 20854790 | |
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 7528766 | ||
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 17617577 | ||
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 9271230 | ||
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 10585853 | ||
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 18635660 | ||
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 29914984 | ||
| Pubmed | SHPS-1 regulates integrin-mediated cytoskeletal reorganization and cell motility. | 1.46e-08 | 3 | 86 | 3 | 11118207 | |
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 34050181 | ||
| Pubmed | Ectodomain shedding of SHPS-1 and its role in regulation of cell migration. | 1.46e-08 | 3 | 86 | 3 | 15123722 | |
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 31099900 | ||
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 2139460 | ||
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 33074246 | ||
| Pubmed | Resistance to collagen-induced arthritis in SHPS-1 mutant mice. | 1.46e-08 | 3 | 86 | 3 | 18455510 | |
| Pubmed | Regulation of Phagocyte Migration by Signal Regulatory Protein-Alpha Signaling. | 1.46e-08 | 3 | 86 | 3 | 26057870 | |
| Pubmed | Essential roles of SHPS-1 in induction of contact hypersensitivity of skin. | 1.46e-08 | 3 | 86 | 3 | 18809435 | |
| Pubmed | Signal regulatory protein alpha (SIRPalpha)/CD47 interaction and function. | 1.46e-08 | 3 | 86 | 3 | 19223164 | |
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 18233962 | ||
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 23559001 | ||
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 22671569 | ||
| Pubmed | Endothelial SIRPα signaling controls VE-cadherin endocytosis for thymic homing of progenitor cells. | 1.46e-08 | 3 | 86 | 3 | 35511221 | |
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 17475843 | ||
| Pubmed | Focal cerebral ischemia upregulates SHP-1 in reactive astrocytes in juvenile mice. | 1.46e-08 | 3 | 86 | 3 | 12742627 | |
| Pubmed | Dendritic cell SIRPα regulates homeostasis of dendritic cells in lymphoid organs. | 1.46e-08 | 3 | 86 | 3 | 25818708 | |
| Pubmed | SIRPα Mediates IGF1 Receptor in Cardiomyopathy Induced by Chronic Kidney Disease. | 5.83e-08 | 4 | 86 | 3 | 35722884 | |
| Pubmed | Macrophages require Skap2 and Sirpα for integrin-stimulated cytoskeletal rearrangement. | 5.83e-08 | 4 | 86 | 3 | 22976304 | |
| Pubmed | 5.83e-08 | 4 | 86 | 3 | 34097709 | ||
| Pubmed | TLR5 mediates CD172α(+) intestinal lamina propria dendritic cell induction of Th17 cells. | 5.83e-08 | 4 | 86 | 3 | 26907705 | |
| Pubmed | 5.83e-08 | 4 | 86 | 3 | 19771158 | ||
| Pubmed | 5.83e-08 | 4 | 86 | 3 | 33028619 | ||
| Pubmed | 5.83e-08 | 4 | 86 | 3 | 26085683 | ||
| Pubmed | 5.83e-08 | 4 | 86 | 3 | 10477552 | ||
| Pubmed | 5.83e-08 | 4 | 86 | 3 | 24143245 | ||
| Pubmed | 5.83e-08 | 4 | 86 | 3 | 32294445 | ||
| Pubmed | 5.83e-08 | 4 | 86 | 3 | 25305319 | ||
| Pubmed | 5.83e-08 | 4 | 86 | 3 | 21401967 | ||
| Pubmed | 5.83e-08 | 4 | 86 | 3 | 14634079 | ||
| Pubmed | 5.83e-08 | 4 | 86 | 3 | 22042861 | ||
| Pubmed | 5.83e-08 | 4 | 86 | 3 | 16697668 | ||
| Pubmed | An essential role for the association of CD47 to SHPS-1 in skeletal remodeling. | 5.83e-08 | 4 | 86 | 3 | 21638321 | |
| Pubmed | Surfactant protein D prevents mucin overproduction in airway goblet cells via SIRPα. | 5.83e-08 | 4 | 86 | 3 | 38245585 | |
| Pubmed | 5.83e-08 | 4 | 86 | 3 | 37095207 | ||
| Pubmed | CD47 Protects Synapses from Excess Microglia-Mediated Pruning during Development. | 5.83e-08 | 4 | 86 | 3 | 30308165 | |
| Pubmed | 5.83e-08 | 4 | 86 | 3 | 9712903 | ||
| Pubmed | 5.83e-08 | 4 | 86 | 3 | 24269920 | ||
| Pubmed | Target cell CD47 regulates macrophage activation and erythrophagocytosis. | 5.83e-08 | 4 | 86 | 3 | 16564725 | |
| Pubmed | 5.83e-08 | 4 | 86 | 3 | 18728125 | ||
| Pubmed | 5.83e-08 | 4 | 86 | 3 | 33416832 | ||
| Pubmed | Augmentation of CD47/SIRPα signaling protects cones in genetic models of retinal degeneration. | 5.83e-08 | 4 | 86 | 3 | 34197341 | |
| Pubmed | 5.83e-08 | 4 | 86 | 3 | 24684700 | ||
| Pubmed | SIRP-alpha-IL-6 axis induces immunosuppressive macrophages in non-small-cell lung cancer. | 5.83e-08 | 4 | 86 | 3 | 37844448 | |
| Pubmed | Increased susceptibility to Salmonella infection in signal regulatory protein α-deficient mice. | 5.83e-08 | 4 | 86 | 3 | 22851710 | |
| Pubmed | SIRPα polymorphisms, but not the prion protein, control phagocytosis of apoptotic cells. | 5.83e-08 | 4 | 86 | 3 | 24145514 | |
| Pubmed | HSF1 promotes the viability of islet β-cells via upregulating SIRPα expression. | 5.83e-08 | 4 | 86 | 3 | 32141563 | |
| Pubmed | CD47 restricts antiviral function of alveolar macrophages during influenza virus infection. | 5.83e-08 | 4 | 86 | 3 | 36437873 | |
| Pubmed | 5.83e-08 | 4 | 86 | 3 | 16127466 | ||
| Pubmed | 5.83e-08 | 4 | 86 | 3 | 23515050 | ||
| Pubmed | 5.83e-08 | 4 | 86 | 3 | 34237430 | ||
| Pubmed | 5.83e-08 | 4 | 86 | 3 | 8810330 | ||
| Pubmed | 5.83e-08 | 4 | 86 | 3 | 9073522 | ||
| Pubmed | 5.83e-08 | 4 | 86 | 3 | 30217731 | ||
| Interaction | ABCE1 interactions | ELOC FLNA FLNB ABLIM1 IGF2R TIMM21 STRAP GLS RPS11 KDR ITGA4 RPL5 | 1.68e-07 | 431 | 82 | 12 | int:ABCE1 |
| Interaction | UBE2M interactions | ELOC FLNA FLNB KLHL24 IGF2R STRAP RPS11 CCT8 CPNE4 CUL7 ITGA4 TST KHDC4 RPL5 | 3.39e-07 | 651 | 82 | 14 | int:UBE2M |
| Interaction | CR1 interactions | 3.58e-06 | 8 | 82 | 3 | int:CR1 | |
| Interaction | FLNA interactions | TDRD15 FLNA FLNB ABLIM1 STRAP CAPZA2 CCT8 COBL SIRPA CUL7 ITGA4 ITGB2 | 1.17e-05 | 648 | 82 | 12 | int:FLNA |
| Interaction | ASB2 interactions | 2.53e-05 | 42 | 82 | 4 | int:ASB2 | |
| Interaction | FLNB interactions | 3.31e-05 | 304 | 82 | 8 | int:FLNB | |
| Interaction | AFF3 interactions | 3.50e-05 | 16 | 82 | 3 | int:AFF3 | |
| Interaction | CHMP4B interactions | IGSF10 ELOC FLNA FLNB ABLIM1 IGF2R CAPN7 RPS11 CAPZA2 COBL ITGA4 RPL5 | 3.63e-05 | 727 | 82 | 12 | int:CHMP4B |
| Interaction | ATG9B interactions | 8.19e-05 | 21 | 82 | 3 | int:ATG9B | |
| Interaction | SIRPG interactions | 9.76e-05 | 4 | 82 | 2 | int:SIRPG | |
| Interaction | CDK9 interactions | FLNA FLNB ABLIM1 AFF3 RPS11 CAPZA2 CCT8 MLLT1 MLLT3 ACTL6A OVOL2 | 1.01e-04 | 685 | 82 | 11 | int:CDK9 |
| Interaction | CAPZA1 interactions | 1.21e-04 | 366 | 82 | 8 | int:CAPZA1 | |
| Cytoband | 13q13 | 3.46e-05 | 5 | 86 | 2 | 13q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q13 | 5.05e-04 | 82 | 86 | 3 | chr13q13 | |
| Cytoband | 20p13 | 9.53e-04 | 102 | 86 | 3 | 20p13 | |
| Cytoband | 6q22.1 | 1.36e-03 | 29 | 86 | 2 | 6q22.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr20p13 | 1.63e-03 | 123 | 86 | 3 | chr20p13 | |
| Cytoband | 3q22.1 | 2.84e-03 | 42 | 86 | 2 | 3q22.1 | |
| Cytoband | 1q32 | 3.85e-03 | 49 | 86 | 2 | 1q32 | |
| Cytoband | 5q32 | 4.66e-03 | 54 | 86 | 2 | 5q32 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.43e-07 | 394 | 65 | 11 | 471 | |
| GeneFamily | Complement system|Sushi domain containing | 1.78e-07 | 36 | 65 | 5 | 492 | |
| GeneFamily | CD molecules|V-set domain containing|C1-set domain containing|Signal regulatory proteins | 4.41e-07 | 5 | 65 | 3 | 747 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.86e-06 | 57 | 65 | 5 | 1179 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 3.67e-06 | 9 | 65 | 3 | 1280 | |
| GeneFamily | Super elongation complex|YEATS domain containing | 7.60e-05 | 4 | 65 | 2 | 1283 | |
| GeneFamily | C1-set domain containing | 4.61e-04 | 42 | 65 | 3 | 591 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 1.88e-03 | 18 | 65 | 2 | 1160 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 2.81e-03 | 163 | 65 | 4 | 590 | |
| Coexpression | RAMALHO_STEMNESS_DN | 2.22e-07 | 78 | 86 | 6 | MM1015 | |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN | CPEB2 KLHL24 NPHP3 EFNB2 BAZ2B CPEB4 ENTPD3 NBEA PARP9 ABLIM3 DCLK1 | 7.95e-07 | 504 | 86 | 11 | M2157 |
| Coexpression | BAKKER_FOXO3_TARGETS_UP | 1.13e-06 | 56 | 86 | 5 | MM903 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | CPEB2 SLC8A1 EML5 GLS CPEB4 NBEA SIRPA REV3L BRSK1 MDGA1 ABLIM3 DCLK1 | 3.15e-06 | 703 | 86 | 12 | M39070 |
| Coexpression | STEARMAN_TUMOR_FIELD_EFFECT_UP | 1.21e-05 | 43 | 86 | 4 | MM1035 | |
| Coexpression | GSE4984_UNTREATED_VS_GALECTIN1_TREATED_DC_DN | 3.90e-05 | 190 | 86 | 6 | M6496 | |
| Coexpression | GSE42724_NAIVE_VS_MEMORY_BCELL_DN | 5.18e-05 | 200 | 86 | 6 | M9793 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_VASCULAR_SMC_1_CELL | 5.60e-05 | 124 | 86 | 5 | M45686 | |
| Coexpression | STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP | 8.10e-05 | 134 | 86 | 5 | MM748 | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-08 | 162 | 86 | 7 | 484ea4ac40de672dcbd2583a52cb7f385c918814 | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-08 | 162 | 86 | 7 | bba144ac5332bab9eba2ccf599703c781a7f88f1 | |
| ToppCell | Control-B_cells-B_cells|Control / group, cell type (main and fine annotations) | 5.15e-08 | 176 | 86 | 7 | d2c353783bd78dc24f28e00d917b88d8294fb5df | |
| ToppCell | control-Lymphoid-B_cell|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.24e-08 | 181 | 86 | 7 | e414303bb90e5fe7b667c2acf9a50f8694b90e54 | |
| ToppCell | NS-control-d_0-4-Lymphoid-B_cell|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.48e-08 | 182 | 86 | 7 | 4b9b55154a79992112c1c467e8752c3cdbb541d9 | |
| ToppCell | Fetal_29-31_weeks-Immune-B_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.98e-08 | 184 | 86 | 7 | f4c9272d5cc4a70df051413b5c60ca6d1d80eb84 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.98e-08 | 184 | 86 | 7 | f81209e6bc01a0140f4487aa8b22eb02fbf0c39c | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-B_lymphocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.00e-07 | 194 | 86 | 7 | b700381f8337b4c6aa50d09ab5bfcd59f2fb2cf3 | |
| ToppCell | severe-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.15e-07 | 198 | 86 | 7 | d5e525d2f2226d06a3fb985ce3a33555ff4b2e7b | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.36e-07 | 158 | 86 | 6 | 121d63b8e2e37107467b170e5b2c798a7dbf6325 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-non-classical_monocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.84e-07 | 160 | 86 | 6 | bc4a93dc5f37829799c37877e751ff3bc122e4ab | |
| ToppCell | droplet-Kidney-nan-24m-Myeloid-CD45____macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.91e-07 | 164 | 86 | 6 | d57faa4fce1f1e9a92aaf5cb920af99323252e4b | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.91e-07 | 164 | 86 | 6 | 11dfd84f5fb90de330858e1e852848832734e004 | |
| ToppCell | droplet-Kidney-nan-24m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.91e-07 | 164 | 86 | 6 | d0b6c29e61d15f4dbe4c1f6e5ed3e10f41f820ab | |
| ToppCell | droplet-Kidney-nan-24m-Myeloid|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.91e-07 | 164 | 86 | 6 | 718cc64b7ef7d03d095be4b2b54c449154da568c | |
| ToppCell | COVID-19-kidney-Bcells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.01e-06 | 171 | 86 | 6 | 8e8fb79968b1a5c34d1d9cad7f9155fabfdb7cc7 | |
| ToppCell | LPS-antiTNF-Lymphocytic_B|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.12e-06 | 174 | 86 | 6 | cc493654ea3517bc6a145c7f787f304929636f86 | |
| ToppCell | LPS-antiTNF-Lymphocytic_B-B_cells-B-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.12e-06 | 174 | 86 | 6 | 9eb3504f9340517ef5d056503044fbdb9ffeb714 | |
| ToppCell | LPS-antiTNF-Lymphocytic_B-B_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.12e-06 | 174 | 86 | 6 | b4c2d1c029fcd0d4926aa79a5b789c713919dcf3 | |
| ToppCell | Control|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.23e-06 | 177 | 86 | 6 | b8ff6940e31b749776e81ae4f5bbd577dba9749c | |
| ToppCell | LPS_only-Lymphocytic_B-B_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.23e-06 | 177 | 86 | 6 | c82332c5f656aa26513e4f7525d5d4d733019725 | |
| ToppCell | LPS_only-Lymphocytic_B|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.23e-06 | 177 | 86 | 6 | 5ed65e08d773d157840317c72e0d43c261d438d4 | |
| ToppCell | LPS_only-Lymphocytic_B-B_cells-B-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.23e-06 | 177 | 86 | 6 | 8a955a7ab84c434f9ad4b467246b8be3cb479406 | |
| ToppCell | normal_Lung-B_lymphocytes-Follicular_B_cells|normal_Lung / Location, Cell class and cell subclass | 1.45e-06 | 182 | 86 | 6 | 13c39228f76495deca6b948483bbde426b3e8c5b | |
| ToppCell | Children_(3_yrs)-Immune-B_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.65e-06 | 186 | 86 | 6 | aa576748921a318798b911a611f05319b95e8d5e | |
| ToppCell | Immune-B_cell|World / Lineage, Cell type, age group and donor | 1.70e-06 | 187 | 86 | 6 | 795690c6306c366e733279491138d0cd9b469b21 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-06 | 189 | 86 | 6 | f0a2d4ef9896d764971ebbc6952510c128bb76e8 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-06 | 189 | 86 | 6 | 378f26f751ab4b470948c35dd8347de72dd12ff7 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.86e-06 | 190 | 86 | 6 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | ILEUM-inflamed-(2)_B_cell|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.92e-06 | 191 | 86 | 6 | 0aa913678456b7d525bd177588f2463f6ed76cd7 | |
| ToppCell | ILEUM-non-inflamed-(2)_B_cell|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.92e-06 | 191 | 86 | 6 | d4496994dd973eb6d0d8b9101a390af237e12fb2 | |
| ToppCell | Nasal_Brush-Immune-Neutrophils|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.98e-06 | 192 | 86 | 6 | 20a7f7beb01df1c4f915ec2f9b5a9dbcab157187 | |
| ToppCell | B_cells-Memory_B_cells|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.98e-06 | 192 | 86 | 6 | eef591095921ede098f41a2b81897b18915bb753 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.98e-06 | 192 | 86 | 6 | aee6522d25e012231cdb905ce047295cb64d6e82 | |
| ToppCell | (4)_B_cells|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.98e-06 | 192 | 86 | 6 | 60f348e38d09312136b077f6a298258475cedd0a | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-06 | 193 | 86 | 6 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | tumor_Lung-B_lymphocytes-Follicular_B_cells|tumor_Lung / Location, Cell class and cell subclass | 2.04e-06 | 193 | 86 | 6 | d0cb4bfc11491c903cb4cc0f823dd1ee239cf5c4 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-06 | 193 | 86 | 6 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | mild-Lymphocytic-B_cells_1|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.10e-06 | 194 | 86 | 6 | fad1986cba9cd23ac68e639d7335fbcd6ae2a4e7 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-B_lymphocytic-memory_B_cell|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.10e-06 | 194 | 86 | 6 | 84aa5ca0356a06fce8799eb1bfa1c362bab34032 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-mesenchymal_progenitor_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-06 | 194 | 86 | 6 | 3d25d6ebec8d1b6001f602257cd15b3ba04cf0c1 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_cell-B_mature|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.16e-06 | 195 | 86 | 6 | 3311a1bf4ed94820b45047d44fc14b14ac72e6fb | |
| ToppCell | Fibroblasts-CD34+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.16e-06 | 195 | 86 | 6 | c6b5249ac8714b1b701cde31d00ab53f28355c36 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.23e-06 | 196 | 86 | 6 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.23e-06 | 196 | 86 | 6 | 4370473693d2dd4a8c451a4c477eb79baa33ae12 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.23e-06 | 196 | 86 | 6 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.23e-06 | 196 | 86 | 6 | 5fe6534af65d43eeacd4b031310242b4f706008b | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_cell-B_naive|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.29e-06 | 197 | 86 | 6 | fd65020089baca78334cecddc96b7a65028c2b7c | |
| ToppCell | control-Lymphocytic-B_cells_1|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.29e-06 | 197 | 86 | 6 | 69dcda785c94f5f15300c73478fa825751c702d5 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-B_lymphocytic|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.29e-06 | 197 | 86 | 6 | e9327b133dab5f6a187cd8713f07205c948ec600 | |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.36e-06 | 198 | 86 | 6 | ab70bf89690410221ec7aa3149bb50ac34433f99 | |
| ToppCell | Immune|World / Lineage, Cell type, age group and donor | 2.36e-06 | 198 | 86 | 6 | 65681b54d13c6997bd90a1c2a12314a80e964fe3 | |
| ToppCell | (0)_Myeloid-(01)_Dendritic_cell-(010)_cDC|(01)_Dendritic_cell / immune cells in Peripheral Blood (logTPM normalization) | 2.36e-06 | 198 | 86 | 6 | 4abc274edac40f8836255fac2371ffd98a32cccd | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.36e-06 | 198 | 86 | 6 | 824461cf44098440ba8bc0df96735423ac65bda1 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macro_CCL|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.43e-06 | 199 | 86 | 6 | 52c06fcc112da21b1d914a896c04bde06fc756fe | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_granulocytic|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.43e-06 | 199 | 86 | 6 | 119807ea333d1dc7743c6b9f03a2c63e09e19541 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.43e-06 | 199 | 86 | 6 | 691e04871cd6cac0ea5fca1b7fd6421df9315db6 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar-Macro_alv_MT|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.43e-06 | 199 | 86 | 6 | 4e0b73d88b1345ec63a9e5629762341e75beb47f | |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.43e-06 | 199 | 86 | 6 | 22001aa733273e784051b7f750e07d99aaf7a225 | |
| ToppCell | COVID-19_Severe-Classical_Monocyte|COVID-19_Severe / Disease condition and Cell class | 2.43e-06 | 199 | 86 | 6 | ea1e2ccde3930fab6d04a9bf130837455c742474 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-B_lymphocytic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.43e-06 | 199 | 86 | 6 | 1aa963ed5205d6d52262b1597a5d08707a95c3ca | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Monocytic-Classical_monocytes|bone_marrow / Manually curated celltypes from each tissue | 2.43e-06 | 199 | 86 | 6 | 2c747e9265594e12d46bd8c8de75c45e83144155 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Artery|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.50e-06 | 200 | 86 | 6 | ac9ead34afa14067171833f5c277eaf06db7b02e | |
| ToppCell | (40)_Monocyte|World / shred on Cell_type and subtype | 2.97e-06 | 206 | 86 | 6 | d78a70f951265ef6df8f64404107be4f53e75d28 | |
| ToppCell | Control-PLT_4|World / Disease Group and Platelet Clusters | 1.23e-05 | 154 | 86 | 5 | a2a03c5e6759c45aeeedf1e68ecb5a0112ef9a20 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-05 | 157 | 86 | 5 | 0ad242320ada7bcb9e29548d3050bf4fd3a07115 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-05 | 157 | 86 | 5 | fe4c9556806203e57522d1986754ebe5a20aa2de | |
| ToppCell | Bronchial_Brush-Epithelial-Goblet_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.43e-05 | 159 | 86 | 5 | 95834b767cfb4fb8c5aeea89c10f3e14a1fd15c1 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-05 | 160 | 86 | 5 | e9e52532131cdc3fb01e81cfc046e3f670cc8e75 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-05 | 160 | 86 | 5 | 2020b6defbaf5b5db12af37f0103ac028a8ca76e | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-05 | 160 | 86 | 5 | af7cf0dc5fe7c02f7d6c436f6dde766c79ff0eae | |
| ToppCell | facs-Lung-nan-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-05 | 162 | 86 | 5 | 3fd6aaf0fbaffc7ab38aa25e46c37ef511e1e704 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-05 | 162 | 86 | 5 | 8134f73eb76693f4f1845f643042fdc1e81c274c | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-non-classical_monocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.61e-05 | 163 | 86 | 5 | bbbc3f0ce2616d07136f69ce682ba1d3790711d9 | |
| ToppCell | TCGA-Uterus-Primary_Tumor-Uterine_Carcinoma-Uterine_Carcinosarcoma-3|TCGA-Uterus / Sample_Type by Project: Shred V9 | 1.61e-05 | 163 | 86 | 5 | d64dd39b077105c73e570ccef70f0e74a2c586ac | |
| ToppCell | severe-Lymphocytic-B_cells_2|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.66e-05 | 164 | 86 | 5 | a1031e9f945a15186ee14c12be47aa11c3c6583b | |
| ToppCell | facs-Lung-nan-3m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 165 | 86 | 5 | 720649f330382ea2a68c64a5344160a048afb8f1 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.71e-05 | 165 | 86 | 5 | 9a6abd0e6b11860231ce5e845c87b8d66f3ef697 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 165 | 86 | 5 | ab6ed7e30096c418e7be2d5eec33feeddd1387d9 | |
| ToppCell | Control-Lymphocytic_B-B_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.81e-05 | 167 | 86 | 5 | a15a70d3837b31cc83a2a9e3f1bbfd77a95f2312 | |
| ToppCell | Control-Lymphocytic_B|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.81e-05 | 167 | 86 | 5 | 956da82394fd6a9f45fc2031796f12cc889542cd | |
| ToppCell | Control-Lymphocytic_B-B_cells-B-cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.81e-05 | 167 | 86 | 5 | 69ed8a4a507190a1a66c4baf1f3e9be21ada39d8 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells-B-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.87e-05 | 168 | 86 | 5 | eeb381b62c7ba263af96de1194ed59e57b6ca3ae | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.87e-05 | 168 | 86 | 5 | 063d0368d656962b335154c230bdcd9236e7c9ad | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.87e-05 | 168 | 86 | 5 | a7c4251d8a83bc30196a444028a35c17c24dc291 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.87e-05 | 168 | 86 | 5 | c0aef5947b1d7e2c81a7481c509feda1687fcd7f | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-non-classical_monocyte|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.87e-05 | 168 | 86 | 5 | c861f80aa12caf54a94d93e38539ff41dc5227a6 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-05 | 169 | 86 | 5 | ba023ee7bb165c2bfbefc2d969ff32ca1eeed33b | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-05 | 169 | 86 | 5 | 0f5e737b265ba333275a0cd289dab029a1542075 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-05 | 169 | 86 | 5 | c96e0f3241d13926dbee9f91c0c8c5bfa7479a0d | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.92e-05 | 169 | 86 | 5 | b059304543876f514d5c7214f1f0a2da00f10a67 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-non-classical_monocyte|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.92e-05 | 169 | 86 | 5 | 945f737984c4de70a4e9c214053b005358053dd5 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.92e-05 | 169 | 86 | 5 | 907e4c7d0df6dd46664d69834251aebca8e1dd1e | |
| ToppCell | droplet-Heart-4Chambers-21m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-05 | 170 | 86 | 5 | 8ea5ab8c890eb91c5b0aae3996e1d1c61c97f0c7 | |
| ToppCell | LPS-IL1RA-Lymphocytic_B-B_cells-B-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.97e-05 | 170 | 86 | 5 | 92e0873f618b2fa60c4d555b10f234d5cbcf3325 | |
| ToppCell | LPS-IL1RA-Lymphocytic_B-B_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.97e-05 | 170 | 86 | 5 | c181991f933b779f99afc3782f292306f209e2ac | |
| ToppCell | LPS-IL1RA-Lymphocytic_B|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.97e-05 | 170 | 86 | 5 | 56284fbfd1e53f67c8c0b7fba64505a4002adba2 | |
| ToppCell | LAM-Lymphoid-B-cell-1|LAM / Condition, Lineage and Cell class | 1.97e-05 | 170 | 86 | 5 | 2b822a95a8d7ee193d40231418d6bd4cf9662842 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.03e-05 | 171 | 86 | 5 | 4ad28ecfde3d529a09b80be908c446bd5274518e | |
| ToppCell | Adult-Immune-B_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.03e-05 | 171 | 86 | 5 | 355a246f3395900342d400f6f7c6640cba0d4d5d | |
| Disease | signal-regulatory protein beta-1 measurement | 1.78e-06 | 9 | 83 | 3 | EFO_0802069 | |
| Disease | threonine measurement | 3.58e-06 | 37 | 83 | 4 | EFO_0009775 | |
| Disease | level of tyrosine-protein phosphatase non-receptor type substrate 1 in blood serum | 7.82e-06 | 2 | 83 | 2 | OBA_2040362 | |
| Disease | immature platelet fraction | 1.80e-05 | 114 | 83 | 5 | EFO_0009187 | |
| Disease | immature platelet measurement | 2.21e-05 | 119 | 83 | 5 | EFO_0803541 | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 2.34e-05 | 3 | 83 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 2.34e-05 | 3 | 83 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | blood sedimentation | 1.63e-04 | 7 | 83 | 2 | EFO_0004304 | |
| Disease | immature platelet count | 2.32e-04 | 106 | 83 | 4 | EFO_0803544 | |
| Disease | platelet measurement | 2.67e-04 | 315 | 83 | 6 | EFO_0005036 | |
| Disease | nephritis (implicated_via_orthology) | 3.47e-04 | 10 | 83 | 2 | DOID:10952 (implicated_via_orthology) | |
| Disease | pneumonia (implicated_via_orthology) | 3.47e-04 | 10 | 83 | 2 | DOID:552 (implicated_via_orthology) | |
| Disease | guanosine diphosphate measurement | 4.23e-04 | 11 | 83 | 2 | EFO_0010494 | |
| Disease | urate measurement, spine bone mineral density | 5.92e-04 | 58 | 83 | 3 | EFO_0004531, EFO_0007701 | |
| Disease | colorectal mucinous adenocarcinoma | 9.14e-04 | 16 | 83 | 2 | EFO_0009361 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 9.14e-04 | 16 | 83 | 2 | C4551479 | |
| Disease | Spondyloepiphyseal Dysplasia | 9.14e-04 | 16 | 83 | 2 | C0038015 | |
| Disease | Schwartz-Jampel Syndrome | 9.14e-04 | 16 | 83 | 2 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 9.14e-04 | 16 | 83 | 2 | C0025237 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 9.14e-04 | 16 | 83 | 2 | C3541456 | |
| Disease | Van Buchem disease | 1.03e-03 | 17 | 83 | 2 | C0432272 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 1.30e-03 | 19 | 83 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | Dyschondroplasias | 1.30e-03 | 19 | 83 | 2 | C0013366 | |
| Disease | Osteochondrodysplasias | 1.30e-03 | 19 | 83 | 2 | C0029422 | |
| Disease | Disproportionate short stature | 1.35e-03 | 77 | 83 | 3 | C0878659 | |
| Disease | Multiple Epiphyseal Dysplasia | 1.44e-03 | 20 | 83 | 2 | C0026760 | |
| Disease | colorectal carcinoma (is_implicated_in) | 1.74e-03 | 22 | 83 | 2 | DOID:0080199 (is_implicated_in) | |
| Disease | glioblastoma (is_implicated_in) | 2.07e-03 | 24 | 83 | 2 | DOID:3068 (is_implicated_in) | |
| Disease | mean platelet volume | 2.27e-03 | 1020 | 83 | 9 | EFO_0004584 | |
| Disease | mitochondrial DNA measurement | 2.36e-03 | 328 | 83 | 5 | EFO_0006312 | |
| Disease | Heart valve disease | 2.43e-03 | 26 | 83 | 2 | C0018824 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YYNPVKEDVQDCGKV | 496 | P51826 | |
| TGEYISKDGVPYCES | 186 | O94929 | |
| TGEYISKDGAPYCEK | 261 | O14639 | |
| SKDGAPYCEKDYQGL | 266 | O14639 | |
| LQGEVAYYAPCGKKL | 766 | Q9UIF8 | |
| CKDPPYKVEESGYAG | 66 | P42568 | |
| YTVRAGYAGEDCPKV | 21 | O96019 | |
| PPAKCGDAEDVYYKS | 1381 | Q9HAR2 | |
| GFGCSKYYEKIPDQM | 541 | Q6RI45 | |
| PTNDGTCIEIGYVKY | 956 | A6QL63 | |
| AVEGKIYLTVYCPKD | 361 | Q96M93 | |
| IGRYCGYEKPDDIKS | 506 | P13497 | |
| ETCSFDGVYQPKIKG | 351 | O75355 | |
| TPCDPKYGAGIYFTK | 726 | Q8IXQ6 | |
| IGYYLKEKKCFPEGT | 391 | O94925 | |
| EGCVYVKCLSPEYAG | 831 | Q9Y2U8 | |
| YYCKAENGVGVPAIK | 106 | Q8NFP4 | |
| CPDYYEAVCGTDGKT | 111 | Q9NQ38 | |
| KVFLCTGADGYVPKY | 2916 | Q5SZK8 | |
| YGCTVFPDGSKEEGK | 316 | Q9HDC5 | |
| GESYVCGSIEPFKKL | 126 | O15075 | |
| ICPKVDSKTVGQYEY | 61 | P52799 | |
| YKALTCEPGYALKDG | 746 | P98095 | |
| DGTYACSYTPVKAIK | 701 | O75369 | |
| NTTVEVKACPGGYYV | 116 | Q8WWZ8 | |
| NCHVYKKYGPEALAG | 561 | Q14999 | |
| GETCYKIYEDEVPFG | 511 | O60449 | |
| GYQKTGDVYKCPVIH | 66 | Q9UKX5 | |
| VCVYTPVGKAEQGKF | 266 | A6NEC2 | |
| DKLYVCEDCGYTGPT | 211 | Q9BRP0 | |
| PGGCYDTKVADIYLA | 486 | Q6P4A8 | |
| CGYLKIKGLTEEYPT | 156 | Q8IVV7 | |
| PGVKLGYEIYDTCTE | 91 | Q5T6X5 | |
| TSDVPGKLIYGQYCE | 521 | P05107 | |
| CKPGYYVAESAEGKV | 1556 | Q9BXP8 | |
| GIYKCTAKNPLGSDY | 2601 | Q6WRI0 | |
| VAGGLTKAIYCYDPV | 506 | Q6TFL4 | |
| KYSCNPGYVLVGEES | 436 | P20023 | |
| CAEPYTVIKESDGGK | 361 | Q8NF50 | |
| GVCYAGIDTDPELKY | 466 | Q7Z5Q1 | |
| DGEPEYNPCGKYMVK | 321 | Q9Y6W3 | |
| GTYGENCEKQSPDYK | 546 | P13671 | |
| GDIPYGKEISYACDT | 1791 | P17927 | |
| YLAKGGSVYPDICTI | 351 | O60678 | |
| KDGSCSVEYIPYEAG | 1406 | P21333 | |
| LGDIPYGKEVSYTCD | 491 | Q2VPA4 | |
| VVDYYNGKGIKPKCS | 531 | Q96A23 | |
| YAEKGYAGKAPVLAA | 891 | O75128 | |
| IEKLAKEVGTSYGCY | 351 | P32189 | |
| KTYGGCEGPDAMYVK | 6 | Q15369 | |
| YACPEVIKGEKYDGR | 196 | Q8TDC3 | |
| CFSYKGKEVPGYIVL | 501 | P13612 | |
| FNVKEKVEGPGCSYL | 246 | Q7Z7F0 | |
| IYEKKYGQVPMCDAG | 71 | Q16568 | |
| GVCYAGIDTDPELKY | 606 | Q17RY0 | |
| CYTAVVPLVYGGETK | 131 | P01591 | |
| SGCYKRHVYEVPSGK | 1841 | Q05BV3 | |
| CKEPPYKVEESGYAG | 66 | Q03111 | |
| EIPAVKESDAGKYYC | 261 | Q96LA5 | |
| SEPGSCYEELLKYVG | 451 | O95180 | |
| VPYGVGKAACDKLAA | 161 | Q96LJ7 | |
| SAAGCKRKYYPGQEE | 296 | Q5T953 | |
| IEGTYIDKKCPFTGN | 51 | P62280 | |
| KVVVTYSKGYPCGGN | 2071 | P11717 | |
| TVLEVKCSCYYGPGD | 756 | B5MCY1 | |
| GDPAEGVYKTYICVE | 431 | Q7Z494 | |
| SLGYEYTGSKKEFPC | 111 | Q86VW1 | |
| YTGSKKEFPCVDGYI | 116 | Q86VW1 | |
| DKPYLYCFRTSKGVG | 276 | Q8NFP9 | |
| AGTYYCVKFRKGSPD | 116 | P78324 | |
| CAAYAHELPKYGVKV | 76 | P46777 | |
| PADVGTYYCVKFRKG | 111 | Q9P1W8 | |
| TPYGYFLISACKDGK | 26 | Q9Y3F4 | |
| YPNGVCTVYGKKIDG | 136 | P47755 | |
| PYTKQFTECGEKGEY | 116 | Q14CN2 | |
| TVFSPGDYICKKGDI | 501 | Q16281 | |
| GTYYCVKFRKGSPDD | 116 | O00241 | |
| TGEKPYKYEECGKVF | 211 | Q9UII5 | |
| KEYRGSFSYKPGACV | 2911 | O60673 | |
| YCDAVKKTSPYDSGP | 256 | O75063 | |
| RIHTGEKPYECTKYG | 311 | Q2M218 | |
| TCVKFYIEGSEPGKQ | 191 | Q9BVV7 | |
| VIHTGEKPYKYEECG | 441 | Q9P255 | |
| PKVIGNDTGAYKCFY | 91 | P35968 | |
| GEKPYVCSECGKAYS | 611 | Q9HCX3 | |
| IIHRGEKPYKYQECG | 176 | Q9NSJ1 | |
| AYLCGKPDVAVYDGS | 261 | Q16762 | |
| YGETCPGLEQYAIKK | 426 | P50990 | |
| KPYEYKDCGKAFVVS | 626 | Q96MR9 | |
| TGECTGSYYCKKGVI | 46 | P32418 |